Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
Avanos Medical (NYSE:AVNS) has announced two significant leadership changes. Scott Galovan has been appointed as Senior Vice President and Chief Financial Officer, effective August 1, 2025. Galovan, who previously served as SVP of strategy and corporate development at Avanos, brings 12 years of company experience and a strong background in acquisitions and divestitures.
Additionally, CEO David Pacitti has been appointed to the company's Board of Directors, also effective August 1, 2025. In his CFO role, Galovan will oversee global finance, treasury, tax, corporate development, investor relations, accounting, and the Enterprise Program Management Office, reporting directly to Pacitti.
Avanos Medical (NYSE:AVNS) ha annunciato due importanti cambiamenti nella leadership. Scott Galovan 猫 stato nominato Senior Vice President e Chief Financial Officer, con effetto dal 1掳 agosto 2025. Galovan, che in precedenza ricopriva il ruolo di SVP della strategia e sviluppo aziendale in Avanos, vanta 12 anni di esperienza in azienda e una solida preparazione in acquisizioni e cessioni.
Inoltre, l'amministratore delegato David Pacitti 猫 stato nominato nel Consiglio di Amministrazione della societ脿, sempre con decorrenza dal 1掳 agosto 2025. Nel suo ruolo di CFO, Galovan supervisioner脿 la finanza globale, tesoreria, fiscalit脿, sviluppo aziendale, relazioni con gli investitori, contabilit脿 e l'Enterprise Program Management Office, riportando direttamente a Pacitti.
Avanos Medical (NYSE:AVNS) ha anunciado dos importantes cambios en su liderazgo. Scott Galovan ha sido nombrado Vicepresidente Senior y Director Financiero, con efecto a partir del 1 de agosto de 2025. Galovan, quien anteriormente se desempe帽aba como SVP de estrategia y desarrollo corporativo en Avanos, aporta 12 a帽os de experiencia en la empresa y una s贸lida trayectoria en adquisiciones y desinversiones.
Adem谩s, el CEO David Pacitti ha sido designado para la Junta Directiva de la compa帽铆a, tambi茅n con efecto a partir del 1 de agosto de 2025. En su rol como CFO, Galovan supervisar谩 las finanzas globales, tesorer铆a, impuestos, desarrollo corporativo, relaciones con inversores, contabilidad y la Oficina de Gesti贸n de Programas Empresariales, reportando directamente a Pacitti.
Avanos Medical (NYSE:AVNS)臧� 霊� 臧�歆� 欤检殧 毽崝鞁� 氤�頇旊ゼ 氚滍憸頄堨姷雼堧嫟. Scott Galovan鞚� 2025雲� 8鞗� 1鞚茧秬搿� 靾橃劃 攵�靷灔 瓴� 斓滉碃鞛毂呾瀯鞛�(CFO)搿� 鞛勲獏霅橃棃鞀惦媹雼�. 鞚挫爠鞐� Avanos鞐愳劀 鞝勲灥 氚� 旮办梾 臧滊皽 SVP搿� 攴茧頃� Galovan鞚� 12雲勳潣 須岇偓 瓴诫牓瓿� 鞚胳垬 氚� 毵り皝 攵勳暭鞐愳劀 臧曤牓頃� 氚瓣步鞚� 臧�歆�瓿� 鞛堨姷雼堧嫟.
霕愴暅 CEO David Pacitti臧� 2025雲� 8鞗� 1鞚茧秬搿� 須岇偓 鞚挫偓須岇棎 鞛勲獏霅橃棃鞀惦媹雼�. CFO 鞐暊鞐愳劀 Galovan鞚� 旮�搿滊矊 旮堨湹, 鞛, 靹鸽, 旮办梾 臧滊皽, 韴瀽鞛� 甏�瓿�, 須岅硠 氚� 旮办梾 頂勲攴鸽灗 甏�毽� 靷靻岆ゼ 齑濌磩頃橂┌, Pacitti鞐愱矊 歆侅爲 氤搓碃頃� 鞓堨爼鞛呺媹雼�.
Avanos Medical (NYSE:AVNS) a annonc茅 deux changements importants au sein de sa direction. Scott Galovan a 茅t茅 nomm茅 Senior Vice President et Chief Financial Officer, 脿 compter du 1er ao没t 2025. Galovan, qui occupait auparavant le poste de SVP en strat茅gie et d茅veloppement corporatif chez Avanos, poss猫de 12 ans d'exp茅rience au sein de l'entreprise ainsi qu'une solide expertise en acquisitions et cessions.
Par ailleurs, le PDG David Pacitti a 茅t茅 nomm茅 au conseil d'administration de la soci茅t茅, 茅galement 脿 compter du 1er ao没t 2025. En tant que CFO, Galovan supervisera les finances mondiales, la tr茅sorerie, la fiscalit茅, le d茅veloppement corporatif, les relations investisseurs, la comptabilit茅 et le bureau de gestion des programmes d'entreprise, rapportant directement 脿 Pacitti.
Avanos Medical (NYSE:AVNS) hat zwei bedeutende F眉hrungswechsel bekannt gegeben. Scott Galovan wurde mit Wirkung zum 1. August 2025 zum Senior Vice President und Chief Financial Officer ernannt. Galovan, der zuvor als SVP f眉r Strategie und Unternehmensentwicklung bei Avanos t盲tig war, bringt 12 Jahre Erfahrung im Unternehmen sowie umfassende Kenntnisse in den Bereichen Akquisitionen und Ver盲u脽erungen mit.
Dar眉ber hinaus wurde CEO David Pacitti ebenfalls zum 1. August 2025 in den Vorstand des Unternehmens berufen. In seiner Funktion als CFO wird Galovan die Bereiche globale Finanzen, Treasury, Steuern, Unternehmensentwicklung, Investor Relations, Buchhaltung und das Enterprise Program Management Office leiten und direkt an Pacitti berichten.
- Internal promotion demonstrates strong succession planning and stability
- New CFO brings 12 years of company experience and proven M&A track record
- CEO joining board strengthens alignment between management and directors
- Potential concentration of power with CEO also serving as board member
Galovan most recently served as Avanos' senior vice president of strategy and corporate development. His background with the company spans 12 years and is highlighted by a proven track record of leading a number of acquisition and divestiture initiatives. Prior to Avanos, he spent 10 years in a variety of strategy, finance, and M&A roles for Newell Brands, Equity Pacific Partners, and Intel Capital.
As CFO, Galovan will oversee the company's global finance, treasury, tax, corporate development, investor relations, and accounting groups, as well as its Enterprise Program Management Office. He will report directly to David Pacitti, Avanos chief executive officer.
"Scott brings a growth-oriented mindset to the CFO role, which will be critical as we look to build on the significant progress we've made with our transformation efforts," said Pacitti. "His ability to drive strategic partnerships, coupled with his deep understanding of market dynamics, will help to shape our next chapter, enhance our long-term planning, and maintain a sharp focus on shareholder value."
Galovan earned a bachelor's degree from BYU and a master's of business administration from the University of
The Company also announced the appointment of Pacitti as a member of its board of directors, effective Aug. 1, 2025.
"On behalf of the entire board, I am pleased to welcome Dave to the Avanos board," said Gary Blackford, Avanos board chair. "His extensive industry experience聽and leadership will further strengthen the Company's vision of being the best at getting patients back to the things that matter."
About Avanos Medical
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in聽Alpharetta,
View original content to download multimedia:
SOURCE Avanos Medical
FAQ
Who is the new CFO of Avanos Medical (NYSE:AVNS)?
What is Scott Galovan's background at Avanos Medical?
What are Scott Galovan's responsibilities as Avanos Medical's new CFO?
When did David Pacitti join Avanos Medical's board of directors?
What educational background does Scott Galovan have?
